Moderna

News

Merck and Moderna's mRNA cancer vaccine aces its first effic...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

News

Old typewriter patent stamp. OCTOBER 1894

Pfizer/BioNTech strike back in Moderna COVID vaccine lawsuit

Pfizer and partner BioNTech have launched a countersuit against Moderna in a patent dispute centring on their mRNA-based vaccines for COVID-19.

News

Pfizer plans considerable 2023 Comirnaty markup

With US government supplies of Covid vaccines predicted to run out in the first quarter of 2023, it has been revealed that Pfizer/BioNTech

News

Digital innovation drives vaccine development

GSK says RSV vaccine shows 94% efficacy in severe disease

GSK's vaccine against respiratory syncytial virus (RSV) is one of the top prospects in its pipeline, but also one with considerable competition, so needs strong data to support the programm

News

US clears Omicron shots from Pfizer, Moderna for children

The US authorities have authorised use of two bivalent COVID-19 booster vaccines from Pfizer/BioNTech and Moderna – targeting the BA.4 and BA.5 subvariants of Omicron – for use in children

News

Merck gets on board with Moderna cancer vaccine in $250m dea...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million.

Merck and Moderna's mRNA cancer vaccine aces its first effic...

Pfizer/BioNTech strike back in Moderna COVID vaccine lawsuit

Pfizer plans considerable 2023 Comirnaty markup

GSK says RSV vaccine shows 94% efficacy in severe disease

US clears Omicron shots from Pfizer, Moderna for children

Merck gets on board with Moderna cancer vaccine in $250m dea...

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Moderna

Editor's Picks